FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 128 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,417,000 | +370750.0% | 196,905 | +49126.2% | 0.19% | – |
| Q2 2019 | $2,000 | -84.6% | 400 | -55.8% | 0.00% | -100.0% |
| Q3 2018 | $13,000 | -60.6% | 906 | -57.1% | 0.00% | -50.0% |
| Q2 2018 | $33,000 | +1000.0% | 2,114 | +1158.3% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 168 | +20.9% | 0.00% | – |
| Q4 2017 | $3,000 | -62.5% | 139 | -24.9% | 0.00% | -100.0% |
| Q3 2017 | $8,000 | -97.2% | 185 | -98.1% | 0.00% | -96.3% |
| Q2 2017 | $286,000 | +31.2% | 9,515 | +57.6% | 0.03% | +28.6% |
| Q1 2017 | $218,000 | +296.4% | 6,039 | +449.0% | 0.02% | +200.0% |
| Q4 2016 | $55,000 | -23.6% | 1,100 | -19.3% | 0.01% | -12.5% |
| Q3 2016 | $72,000 | -30.1% | 1,363 | -45.5% | 0.01% | -42.9% |
| Q2 2016 | $103,000 | +41.1% | 2,500 | +38.9% | 0.01% | +40.0% |
| Q1 2016 | $73,000 | +17.7% | 1,800 | -28.0% | 0.01% | +11.1% |
| Q2 2015 | $62,000 | +24.0% | 2,500 | +13.6% | 0.01% | +28.6% |
| Q1 2015 | $50,000 | +38.9% | 2,200 | -29.0% | 0.01% | +40.0% |
| Q3 2014 | $36,000 | – | 3,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |